Wedbush lowered its price target for Resolve stock to $59 from $68 while Raymond James cut its price target to $62 from $73, with both analysts maintaining their outperform rating. Meanwhile, Credit Suisse trimmed its price target to $58 from $74 while reiterating its outperform rating.
Revolve reported Q1 earnings late Tuesday of $0.30 per diluted share, unchanged from a year earlier. Analysts polled by Capital IQ expected $0.27.
Net sales for the quarter ended March 31 were $283.5 million, up from $178.9 million a year earlier. Analysts surveyed by Capital IQ expected $256.8 million.
Price: 34.19, Change: -9.32, Percent Change: -21.42
|OPEC Falls Short of Crude Oil Output Targets in June...|
|Wells Fargo Upgrades Excelerate Energy to Overweight...|
|Hong Kong Hang Seng Inches Higher Despite Pandemic C...|
|AstraZeneca to Acquire Cancer Drug Maker TeneoTwo|
|JPMorgan Adjusts Tesla's Price Target to $385 From $...|